MedTrace Logo

Skin Fluorescent Imaging (SFI) System in Patients With Nevi

NCT04368247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-08-07

No results posted yet for this study

Summary

The Sponsor has developed the Skin Fluorescent Imaging (SFI) system, an in vivo imaging modality, for the purpose of providing physicians with insight into the biological changes occurring during tissue remodeling in a nevus.

Conditions

  • Nevus
  • Dysplasia; Epithelial

Interventions

DIAGNOSTIC_TEST

Skin Fluorescent Imaging

Application of reagents, then imaging and scoring

Sponsors & Collaborators

  • Orlucent, Inc

    lead INDUSTRY

Principal Investigators

  • Cathy Shachaf, PhD · President

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2023-06-30
Completion
2023-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04368247 on ClinicalTrials.gov